LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma.
- DOI
- 10.1016/j.jcmgh.2020.06.009
- Published
- 2020
- Container
- Cellular and molecular gastroenterology and hepatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcmgh.2020.06.009,
title = {LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma.},
author = {Zhu YX and Li CH and Li G and Feng H and Xia T and Wong CH and Fung FKC and Tong JH and To KF and Chen R and Chen Y},
year = {2020},
journal = {Cellular and molecular gastroenterology and hepatology},
doi = {10.1016/j.jcmgh.2020.06.009},
url = {https://doi.org/10.1016/j.jcmgh.2020.06.009}
}RIS
TY - JOUR TI - LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. AU - Zhu YX AU - Li CH AU - Li G AU - Feng H AU - Xia T AU - Wong CH AU - Fung FKC AU - Tong JH AU - To KF AU - Chen R AU - Chen Y PY - 2020 JO - Cellular and molecular gastroenterology and hepatology DO - 10.1016/j.jcmgh.2020.06.009 UR - https://doi.org/10.1016/j.jcmgh.2020.06.009 ER -
APA
YX, Z., CH, L., G, L., H, F., T, X., CH, W., FKC, F., JH, T., KF, T., R, C., & Y, C. (2020). LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma.. Cellular and molecular gastroenterology and hepatology. https://doi.org/10.1016/j.jcmgh.2020.06.009
Source records
- pubmed · retrieved 2026-09-25T13:12:13.829Z